410 ILCS 725/1
Short title
Short title. This Act may be cited as the Pharmaceutical and Health Affordability: Restrictions on Manufacturers' Amoral Behavior through Reasonable Oversight Act.(Source: P.A. 103-367, eff. 1-1-24.)
Illinois Compiled Statutes 410 ILCS 725 — Pharmaceutical and Health Affordability: Restrictions on Manufacturers' Amoral Behavior through Reasonable Oversight Act.
Illinois · statute · 410 ILCS 725 · 5 active provisions
Provisions
410 ILCS 725/2
Legislative findings
Legislative findings. (a) The General Assembly finds that public reports by Congress and the news media have demonstrated the devastating impact that increasing drug prices can have on the 60% of Americans and 90% of seniors that take prescription drugs. (b) The General Assembly further finds that public reports descri…
410 ILCS 725/5
Definitions
Definitions. As used in this Act: "Essential off-patent or generic drug" means any prescription drug sold within the State: (1) for which all exclusive marketing rights, if any, granted under the Federal Food, Drug, and Cosmetic Act, Section 351 of the federal Public Health Service Act, and federal patent law have expi…
410 ILCS 725/10
Price gouging prohibited
Price gouging prohibited. (a) A manufacturer or wholesale drug distributor shall not engage in price gouging in the sale of an essential off-patent or generic drug that is ultimately sold in Illinois. It is not a violation of this Act for a wholesale distributor to increase the price of an essential off-patent or gener…
410 ILCS 725/99
Effective date
Effective date. This Act takes effect January 1, 2024.(Source: P.A. 103-367, eff. 1-1-24.)